Skip to content
Sunday, August 1, 2021
Latest:
  • FROM THE LABS: New COVID-19 vaccine formulation produces effective vaccine candidate
  • Turning the molecular clock back on halts neuroblastoma tumor growth
  • Progress Notes MS1/MS4 profile: Will Frankel
  • Communications and public health: An interview with Monisha Arya, M.D., M.P.H
  • Naturally occurring antibodies recognize many different noroviruses

Baylor College of Medicine Blog Network

Baylor College of Medicine Blog Network

  • Blog Network
  • Momentum
    • About Momentum
    • Contributors
      • Dana Benson
      • Nicole Blanton
      • Molly Chiu
      • Kaylee Dusang
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Resources
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Editors
    • Connect With Us
  • bcm.edu

CDK4/6 inhibitor therapy

From The Labs 

Interferon linked to ER+/HER- metastatic breast cancer resistance to therapy

March 12, 2021March 12, 2021 Ana Rodríguez 0 Comments CDK4/6 inhibitor therapy, endocrine therapy, ER+/HER2- breast cancer, Interferon, Metastatic breast cancer, Research, resistance to cancr treatment

Both preclinical models and tumor samples from patients with ER+/HER2- breast cancer link high IFN signaling to resistance to treatment.

Read more

From the Labs Image of the Month

From The Labs Image of the Month From the Labs features an image of autofluorescence of pollen from Lilium orientalis "Stargazer." Image courtesy of J. Kirk/ OiVM.

Healthy Habits: A DOC-umentary Series

https://youtu.be/MAXO08xs9fc

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951